Font Size: a A A
Keyword [HSCT]
Result: 121 - 140 | Page: 7 of 10
121. A Clinical Study Of Decitabine Combined With Standard Conditioning Regimen Prior To Allo-HSCT In The Treatment Of Relapse/refractory Acute Myeloid Leukemia
122. The Clinical Study Of Allo-HSCT In Severe Aplastic Anemia And The Interactions Between Umbilical Cord Mesenchymal Stem Cells And Tacrolimus For Inhibition Of GVHD
123. To Discuss The Distribution Of Donor-specific AKIR And Its Clinical Significance After Unrelated Allo-HSCT
124. Pathogenesis Of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
125. Expression Of PPARĪ³ In Patients After Allo-HSCT Correlates With AGVHD
126. Impact Of SNP On Prognosis Of Patients After Matched Unrelated Allo-HSCT
127. The Mechanism Of DSA On The Damage Of NK Cells To Endothelial Cells And The Clinical Observation Of Small Samples In Haplo-HSCT
128. The Effect And Predictive Value Of Intestinal Microbiota On AGVHD After Allo-HSCT
129. Relapse Of AML After Allo-HSCT:Risk Factors And Mechanisms
130. The Effect And Molecular Mechanism Of Kras In Acute Graft-versus-Host Disease
131. Chitinase 3-like-1 Deficient Donor Splenocytes Accentuated The Pathogenesis Of Acute Graft-versus-host Diseases
132. A Clinical Investigation Of Bloodstream Infection In Patients With Hematopoietic Stem Cell Transplantation And The Study Of CP-PGN Anti-infection Treatment
133. Study On Characteristics And Dynamics Of TCR Repertoire Early After Allo-HSCT
134. The Clinical Situation And Efficacy Analysis Of EBV Infection In Children After Allo-HSCT
135. Clinical Prognostic Analysis Of Allogeneic Hematopoietic Stem Cell Transplantation In 189 Patients With Myelodysplastic Syndrome
136. Clinical Analysis Of Central Nervous System Complications After Allo-HSCT
137. Clinical Retrospective Study And Analysis Of Its Influencing Factors Of Liver CGVHD After Hematopoietic Stem Cell Transplantation
138. Clinical Study Of Combined Use Of Post Cyclophosphamide And Post Anti Thymocyte Globulin In The Prevention Of GVHD After Haplo-HSCT
139. Clinical Efficacy And Prognostic Factors Analysis Of Hematopoietic Stem Cell Transplantation In Hematologic Diseases
140. To Investigate The Immune Reconstruct Regularity Profile Of KIR Gene In Allo-HSCT
  <<First  <Prev  Next>  Last>>  Jump to